IMI1 – Call 2

IMI1 – Call 2 was launched on 27 November 2009 with the following topics:

  • New tools for target validation to improve drug efficacy
  • Molecular biomarkers - accelerating cancer therapy development and refining patient care
  • Imaging biomarkers for anticancer drug development
  • Identification and development of rapid point of care microbiologic diagnostic tests to facilitate clinical practice and conduct of clinical trials
  • Understanding aberrant adaptive immunity mechanisms in human chronic immune-mediated diseases: rheumatoid arthritis, systemic lupus erythematosus & inflammatory bowel disease
  • Translational research in rheumatoid arthritis (RA) and RA like diseases: bridging between animal models and humans
  • Drug/disease modelling: library & framework (DDMLF)
  • Open pharmacological space (OPS)
  • Using electronic health records (EHR) to support and enhance medical research

 More information on the topics can be found in IMI’s press release and in the Call text. Other relevant documents, including documents for applicants, the list of expert reviewers, and the independent observers’ reports of the evaluations, can be found on the IMI1 Call documents page.



The projects resulting from IMI1 – Call 2 are:

  • BTCure - Be the cure
    factsheet | website
  • DDMoRe - Drug disease model resources
    factsheet | website
  • EHR4CR - Electronic health records systems for clinical research
    factsheet | website
  • Onco Track - Methods for systematic next generation oncology biomarker development
    factsheet | website
  • Open PHACTS - The Open pharmacological concepts triple store
    factsheet | website
  • Predect - New models for preclinical evaluation of drug efficacy in common solid tumours
    factsheet | website
  • Quic-Concept - Quantative imaging in cancer: connecting cellular process with therapy
    factsheet | website
  • RAPP-ID - Development of rapid point-of-care test platforms for infectious diseases
    factsheet | website